The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than ...

Doctors, patients and researchers are at the very beginning of understanding how the new class of obesity drugs interact with ...

ATLANTA — More than half of the people who stop using GLP-1 drugs regain at least some of the weight within a year, new real-world data showed. The new findings, from a large national claims database, ...

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, ...

In a real-world study, patients with psoriatic disease treated with an IL-17 targeted biologic and a GLP-1 agonist ...